IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
Recruiting · NCT03809728 · Interventional (participants receive a specific treatment) · Lead sponsor: Central Hospital, Nancy, France
View the official record on ClinicalTrials.gov →Interventions studied
Samples of the resected specimenendoscopic biopsysamples of the oral cavity
What this trial is about
Interventional study of a group of patients with an inflammatory bowel disease (IBD; Crohn's disease (CD) or ulcerative colitis (UC)) to identify predictive and prognostic biomarkers of natural history and response to biotherapies.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age\>=18 years
- Patients with an established diagnosis of CD or UC (clinical, biological, radiological, endoscopic or histologic criteria)
- Patients \>=45 kg
- Affiliated member of the Social Security system
Exclusion criteria
- Patients with an undetermined colitis
- Patients with a non established diagnosis of CD
- Women of childbearing age without a method of contraception
- Persons covered by articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code
- Pregnant women, breastfeeding women
- \-- Age \< 18 years
- Persons under legal protection
- Person who does not have the capacity to consent
- Persons under the age of 18 years who are deprived of their liberty by decision of a judicial or administrative authority (articles L. 3212-1 and L. 3213-1).
Where it is running
2 locations listed.
- CHRU Nancy - Vandœuvre-lès-Nancy, France
- CHRU Nancy - Vandœuvre-lès-Nancy, France